Publications in collaboration with researchers from Fundación Jiménez Díaz (86)

2024

  1. Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z)

    British Journal of Cancer

  2. Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

    British Journal of Cancer, Vol. 130, Núm. 8, pp. 1402-1413

  3. Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest

    Molecular Oncology

2023

  1. DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer

    Biomedicines, Vol. 11, Núm. 10

  2. Functional Proteomics Characterization of the Role of SPRYD7 in Colorectal Cancer Progression and Metastasis

    Cells, Vol. 12, Núm. 21

  3. Proteomics analysis of prefrontal cortex of Alzheimer’s disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology

    Cellular and Molecular Life Sciences, Vol. 80, Núm. 6

  4. Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer

    eLife, Vol. 12

2022

  1. Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis

    Cells, Vol. 11, Núm. 3

2021

  1. Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma

    Annals of Diagnostic Pathology, Vol. 53

  2. Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody Biomarkers

    Journal of Proteome Research, Vol. 20, Núm. 11, pp. 5115-5130

  3. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer

    Engineering, Vol. 7, Núm. 10, pp. 1393-1412

  4. Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer

    Biomedicine and Pharmacotherapy, Vol. 144

2020

  1. Early detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice

    PloS one, Vol. 15, Núm. 6, pp. e0234606

  2. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis

    Journal of Proteomics, Vol. 214

  3. Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer

    PLoS biology, Vol. 18, Núm. 6, pp. e3000732

  4. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study

    Neuroendocrinology, Vol. 110, Núm. 1-2, pp. 50-62

  5. TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma

    Pathology and Oncology Research, Vol. 26, Núm. 2, pp. 861-865

  6. Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas

    Neuroendocrinology, Vol. 111, Núm. 1-2, pp. 146-157

  7. The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 5

2019

  1. CX3CL1–CX3CR1 axis: A new player in coeliac disease pathogenesis

    Nutrients, Vol. 11, Núm. 11